[Tiapride in the treatment of irreversible tardive dyskinesia--initial experiences]

Twelve patients on a chronic psychiatric ward with NL-induced permanent TD were treated with 300 mg tiapride daily for at least 3 weeks. Clinical assessment of TD was performed with AIM-Scale before and after 3 weeks' therapy, showing a significant effect of treatment. These preliminary findings were controlled in a blind study, showing again a significant therapeutic effect of tiapride.